Bouchard J, Acharya A, Cerda J, et al. A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol. 2015;10(8):1324–31. https://doi.org/10.2215/CJN.04360514.

Article  PubMed  PubMed Central  Google Scholar 

Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2020;98(2):294–309. https://doi.org/10.1016/j.kint.2020.04.020.

Article  PubMed  PubMed Central  Google Scholar 

Case J, Khan S, Khalid R, et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730. https://doi.org/10.1155/2013/479730.

Article  PubMed  PubMed Central  Google Scholar 

Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Crit Care. 2016;20(1):188. https://doi.org/10.1186/s13054-016-1353-y.

Article  PubMed  PubMed Central  Google Scholar 

Perazella MA, Rosner MH. Drug-induced acute kidney injury. Clin J Am Soc Nephrol. 2022;17(8):1220–33. https://doi.org/10.2215/CJN.11290821.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davies LE, Spiers G, Kingston A, et al. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181–7. https://doi.org/10.1016/j.jamda.2019.10.022.

Article  PubMed  Google Scholar 

Mitchell AM, Jones AE, Tumlin JA, et al. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol. 2010;5(1):4–9. https://doi.org/10.2215/CJN.05200709.

Article  PubMed  PubMed Central  Google Scholar 

Spence JD, Grosser T, FitzGerald GA. Acetaminophen, nonsteroidal anti-inflammatory drugs, and hypertension. Hypertension. 2022;79(9):1922–6.

Article  CAS  PubMed  Google Scholar 

Lee GB, Hosking SM, Etherton-Beer C, et al. Defining polypharmacy in older adults: a cross-sectional comparison of prevalence estimates calculated according to active ingredient and unique product counts. Int J Clin Pharm. 2025;47(3):824–33. https://doi.org/10.1007/s11096-025-01882-7.

Article  PubMed  PubMed Central  Google Scholar 

Hsu CN, Lee CT, Su CH, et al. Incidence, outcomes, and risk factors of community-acquired and hospital-acquired acute kidney injury: a retrospective cohort study. Medicine (Baltimore). 2016;95(19):e3674.

Article  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097.

Article  PubMed  PubMed Central  Google Scholar 

EndNote solution | your smarter way to research. Superior business solutions. https://sbs-me.com/endnote-your-smarter-way-to-researc. Accessed 2 May 2025.

Stang A. Critical evaluation of the Newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. https://doi.org/10.1007/s10654-010-9491-z.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. https://doi.org/10.1002/sim.1186.

Article  PubMed  Google Scholar 

Page MJ, Higgins JPT, Sterne JAC. Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [last updated August 2024]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane, 2024. https://www.cochrane.org/authors/handbooks-and-manuals/handbook. Accessed 2 May 2025.

Akimoto H, Hayakawa T, Nagashima T, et al. Detection of potential drug-drug interactions for risk of acute kidney injury: a population-based case-control study using interpretable machine-learning models. Front Pharmacol. 2023;14:1176096.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chao CT, Tsai HB, Wu CY, et al. Cumulative cardiovascular polypharmacy is associated with the risk of acute kidney injury in elderly patients. Medicine (Baltimore). 2015;94(31):e1251. https://doi.org/10.1097/MD.0000000000001251.

Article  CAS  PubMed  Google Scholar 

Duong H, Tesfaye W, Van C, et al. Hospitalisation due to community-acquired acute kidney injury and the role of medications: a retrospective audit. J Clin Med. 2023;12(9):3347. https://doi.org/10.3390/jcm12093347.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Formica M, Politano P, Marazzi F, et al. Acute kidney injury and chronic kidney disease in the elderly and polypharmacy. Blood Purif. 2018;46(4):332–6. https://doi.org/10.1159/000492149.

Article  CAS  PubMed  Google Scholar 

Ho YF, Hsieh KL, Kung FL, et al. Nephrotoxic polypharmacy and risk of contrast medium-induced nephropathy in hospitalized patients undergoing contrast-enhanced CT. AJR Am J Roentgenol. 2015;205(4):703–8. https://doi.org/10.2214/AJR.15.14329.

Article  PubMed  Google Scholar 

Laville SM, Gras-Champel V, Hamroun A, et al. Kidney function decline and serious adverse drug reactions in patients with CKD. Am J Kidney Dis. 2024;83(5):601-614.e1. https://doi.org/10.1053/j.ajkd.2023.09.012.

Article  CAS  PubMed  Google Scholar 

Nishtala PS, Chyou TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73. https://doi.org/10.1002/pds.4960.

Article  CAS  PubMed  Google Scholar 

Oda T, Jödicke AM, Robinson DE, et al. Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the United Kingdom. J Bone Miner Res. 2022;37(7):1270–8. https://doi.org/10.1002/jbmr.4573.

Article  CAS  PubMed  Google Scholar 

Pinheiro HS, Moraes CC, Esquerdo GAM, et al. Antimicrobial data set and occurrence of acute kidney injury in patients admitted to a hospital in Western Pará, Brazil. Data Brief. 2025;60:111498. https://doi.org/10.1016/j.dib.2025.111498.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang Y, Zuo C, et al. Investigation of vancomycin-associated acute kidney injury and risk factors in elderly patients. Drug evaluation research. Herald Med 2025:1–8 (in Chinese).

Google Scholar 

Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72. https://doi.org/10.1111/jgs.13153.

Article  PubMed  PubMed Central  Google Scholar 

Ngcobo NN. Influence of ageing on the pharmacodynamics and pharmacokinetics of chronically administered medicines in geriatric patients: a review. Clin Pharmacokinet. 2025;64(3):335–67. https://doi.org/10.1007/s40262-024-01466-0.

Article  PubMed  PubMed Central  Google Scholar 

Kua CH, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(3):362-372.e11. https://doi.org/10.1016/j.jamda.2018.10.026.

Article  PubMed  Google Scholar 

Liu C, Yan S, Wang Y, et al. Drug-induced hospital-acquired acute kidney injury in China: a multicenter cross-sectional survey. Kidney Dis (Basel). 2021;7(2):143–55. https://doi.org/10.1159/000510455.

Article  PubMed  Google Scholar 

Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003;60(11):1123–9. https://doi.org/10.1093/ajhp/60.11.1123.

Article  PubMed  Google Scholar 

Little MO. Updates in nutrition and polypharmacy. Curr Opin Clin Nutr Metab Care. 2018;21(1):4–9. https://doi.org/10.1097/MCO.0000000000000425.

Article  CAS